Published in Arch Int Pharmacodyn Ther on October 01, 1983
Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol (2000) 6.55
Quality of life consequences of chemotherapy-induced emesis. Qual Life Res (1992) 1.40
Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J Biol Chem (1998) 1.36
Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology (1991) 1.28
Hindlimb motor neurons require Cu/Zn superoxide dismutase for maintenance of neuromuscular junctions. Am J Pathol (1999) 1.13
Health care utilization in patients with gout. Semin Arthritis Rheum (2010) 1.06
Evaluation of an implantable venous access system in a general oncology population. Oncology (1992) 1.06
A new look at dry eye disease and its treatment. Adv Ther (2000) 0.96
Postoperative nausea and vomiting after discharge from outpatient surgery centers. Anesth Analg (1995) 0.95
The binding of [3H]diazepam to rat brain homogenates. J Pharmacol Exp Ther (1978) 0.93
Opiate and muscarinic ligand binding in five limbic areas after bilateral olfactory bulbectomy. Brain Res (1980) 0.92
beta-Carboline-3-carboxylic acid ethyl ester antagonizes diazepam activity. Nature (1980) 0.89
Comparison of Intralipid 10% and Intralipid 20% as a source of energy and essential fatty acids--a multicenter study. Acta Chir Scand Suppl (1983) 0.85
Inhibition of rabbit reticulocyte protein kinases by hemin. Biochem Biophys Res Commun (1976) 0.84
Laminar distribution of putative neurotransmitter amino acids and ligand binding sites in the dog olfactory bulb. J Neurochem (1980) 0.83
Costs incurred by outpatient surgical centers in managing postoperative nausea and vomiting. J Clin Anesth (1995) 0.80
Ligand binding studies in the mouse olfactory bulb: identification and characterization of a L-[3H]carnosine binding site. Brain Res (1978) 0.80
Cell suspensions from rat olfactory neuroepithelium: biochemical and histochemical characterization. Brain Res (1979) 0.80
Nausea and vomiting and cancer patients' quality of life: a discussion of Professor Selby's paper. Br J Cancer Suppl (1992) 0.79
In vitro and in vivo effects on brain GABA metabolism of (S)-4-amino-5-fluoropentanoic acid, a mechanism-based inactivator of gamma-aminobutyric acid transaminase. Life Sci (1983) 0.79
Production and characterization of recombinant mouse brain-derived neurotrophic factor and rat neurotrophin-3 expressed in insect cells. J Neurochem (1994) 0.78
Aging does not alter the sensitivity of benzodiazepine receptors to GABA modulation. Neurobiol Aging (1987) 0.77
A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits. Am J Gastroenterol (1991) 0.77
Heterogeneity of brain benzodiazepine receptors demonstrated by [3H]propyl beta-carboline-3-carboxylate binding. Mol Pharmacol (1982) 0.76
Pharmacological and physiological properties of benzodiazepine binding sites in rodent brown adipose tissue. Comp Biochem Physiol C (1984) 0.76
Stress ulcers and organ failure in intubated patients in surgical intensive care units. Ann Surg (1992) 0.75
Influence of unilateral olfactory bulbectomy on opiate and other binding sites in the contralateral bulb. Brain Res (1980) 0.75
Activity of octreotide acetate in a total nutrient admixture. Am J Hosp Pharm (1991) 0.75
Thermodynamic changes associated with benzodiazepine and alkyl beta-carboline-3-carboxylate binding to rat brain homogenates. Mol Pharmacol (1982) 0.75
The neurochemical sequelae of olfactory bulbectomy. Life Sci (1980) 0.75
Regional changes in [3H]diazepam binding in the brains of mice after removal of the olfactory bulbs. Exp Neurol (1981) 0.75
Synthesis of beta-spiro[pyrrolidinoindolines], their binding to the glycine receptor, and in vivo biological acitivity. J Med Chem (1977) 0.75
The binding of strychnine and strychnine analogs to synaptic membranes of rat brainstem and spinal cord. J Pharmacol Exp Ther (1977) 0.75
In vivo inactivation of gamma-aminobutyric acid-alpha-ketoglutarate transaminase by 4-amino-5-fluoropentanoic acid. Biochem Biophys Res Commun (1981) 0.75
Realities of conducting pharmacoeconomic evaluations as part of clinical trials. Pharm Pract Manag Q (1995) 0.75
Effects of cations and anions on the binding of 3H-diazepam to rat brain. Proc Soc Exp Biol Med (1978) 0.75
Oncology nurses' attitudes, perceptions, and knowledge of quality-of-life assessment in patients with cancer. Oncol Nurs Forum (1994) 0.75
Heterogeneity of benzodiazepine binding sites: a review of recent research. Pharmacol Biochem Behav (1985) 0.75
Peripheral and central-type benzodiazepine binding sites in mammalian ocular tissues. Exp Eye Res (1984) 0.75
L-[3H]Carnosine binding in the olfactory bulb. II. Biochemical and biological studies. Brain Res (1979) 0.75
Photolabeling of benzodiazepine receptors spares [3H]propyl beta-carboline binding. Pharmacol Biochem Behav (1982) 0.75
Nausea and vomiting after abdominal surgery. Clin Pharm (1992) 0.75
Binding of beta-carboline-3-carboxylic acid ethyl ester to mouse brain benzodiazepine receptors in vivo. Eur J Pharmacol (1981) 0.75
Cholecystokinin in vivo reduces binding to rat hypothalamic beta-adrenergic sites. Peptides (1984) 0.75
Selective inhibition of [3H]lysergic acid diethylamide binding to mouse brain membranes by ethanol. J Pharm Pharmacol (1981) 0.75